Study of How Safe and Effective Tarlatamab is in Brain Cancers

NCT06776250 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Astrocytic Tumor
Oligodendroglial Tumor

Interventions

DRUG: Tarlatamab

Sponsor

University Health Network, Toronto

Collaborators

[object Object]